Donanemab for Alzheimer's Gets Thumbs Up From FDA Panel
An 11-member advisory panel to the US Food and Drug Administration unanimously endorsed the anti-amyloid donanemab for early Alzheimer's disease.
Source: medscape.com
Howard Fillit News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Howard Fillit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Howard Fillit Today - Breaking & Trending Today
FDA Panel Endorses Donanemab to Treat Early-Stage Alzheimer Disease
Donanemab was able to significantly slow clinical progression of Alzheimer disease and amyloid and tau pathology at 76 weeks of treatment.
Source: pharmacytimes.com
VACCINEXPAR : 12th Alzheimer's & Parkinson's Drug Development Summit Presentation
Targeting Neuroinflammation to Modulate Reactive Astrocytes for Treatment of Neurodegenerative Disease ...
Source: marketscreener.com
Neurotech for Dementia Screening in Outpatient Clinical Markets
Diagnosis of Alzheimer's and related dementias is broken. As blood tests emerge, what is the role of digital screening tools and neurotechnologies in clinical practice?
Source: forbes.com
A look at drug development in Alzheimer's disease
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more
Source: bioworld.com